Pharmaceutical News

RSS

Global Vaccine Summit to be held in Abu Dhabi from Apr. 24-25

Under the patronage of His Highness General Sheikh Mohamed bin Zayed bin Sultan Al Nahyan , Crown Prince of Abu Dhabi and Deputy Supreme Commander of the UAE Armed Forces, and in partnership with United Nations Secretary-General Ban Ki -moon and Bill Gates , co-chair of the Bill & Melinda Gates Foundation, it was announced today that a Global Vaccine Summit will be held in Abu Dhabi on April 24-25, 2013.

7 Mar 2013

Study shows how nanoparticles can be formed to efficiently carry cancer drugs to tumor cells

Small particles loaded with medicine could be a future weapon for cancer treatment. A recently-published study shows how nanoparticles can be formed to efficiently carry cancer drugs to tumor cells. And because the particles can be seen in MRI images, they are traceable.

7 Mar 2013

University of Sunderland pharmaceutical scientists receive CFUK grant for research into cystinosis

Pharmaceutical scientists at the University of Sunderland have been awarded £125,000 by the Cystinosis Foundation (CF) UK to fund the next stage of their research into a rare genetic disease.

7 Mar 2013

Drugs that inhibit buildup of acylcarnitines may block axonal degeneration

Anyone whose hand or foot has "fallen asleep" has an idea of the numbness and tingling often experienced by people with peripheral nerve damage. The condition also can cause a range of other symptoms, including unrelenting pain, stinging, burning, itching and sensitivity to touch.

6 Mar 2013

Laboratorios Grifols, Cadence announce new supply agreement for OFIRMEV

Cadence Pharmaceuticals, Inc., a biopharmaceutical company focused on acquiring, in-licensing, developing and commercializing proprietary products principally for use in the hospital setting, today announced a new supply agreement with Laboratorios Grifols, S.A. for the development, manufacture and supply of commercial quantities of OFIRMEV (acetaminophen) injection in flexible plastic bags.

6 Mar 2013

FDA accepts AMAG’s Feraheme sNDA for review

AMAG Pharmaceuticals, Inc. today announced that the United States Food and Drug Administration (FDA) has accepted for review the company's supplemental new drug application (sNDA) for Feraheme (ferumoxytol) Injection for Intravenous (IV) use, which was submitted to the FDA in December 2012.

6 Mar 2013

Study shows how fish oils help lower blood pressure via vasodilation at ion channels

Omega-3 fatty acids found in oily fish may have diverse health-promoting effects, potentially protecting the immune, nervous, and cardiovascular systems.

6 Mar 2013

Scientists decode the antihypertensive impact of omega-3 fatty acids

Scientists of Friedrich Schiller University Jena and Jena University Hospital decode the antihypertensive impact of omega-3 fatty acids. In two newly published articles for the well-known science magazine 'Proceedings of the National Academy of Sciences, USA' they describe how they analyzed the impact of omega-3 fatty acids on a systemic level and they also described the underlying molecular mechanisms for the first time.

6 Mar 2013

National Jewish Health receives U.S. patent for POPG and related compounds

Dennis Voelker, PhD, professor of medicine at National Jewish Health, has been awarded a U.S. patent (#8,367,643) for various lipids and related compounds that can inhibit inflammation and infection in the lungs, especially those caused by influenza and respiratory syncytial virus (RSV).

5 Mar 2013

U.S. researchers report 'functional cure' for infant born with HIV

"A baby born with the virus that causes AIDS appears to have been cured, scientists announced Sunday, describing the case of a child from Mississippi who's now two and a half and has been off medication for about a year with no signs of active infection," the Associated Press reports.

5 Mar 2013

Much anticipation surrounds push to bring more transparency to medicine

After years of anticipation, all of the nation's drug and medical device makers must soon begin publicly reporting payments they make to U.S. physicians, according to final regulations announced this afternoon by the federal government.

5 Mar 2013

Sanofi, DBV Technologies partner to produce Viaskin's Active Pharmaceutical Ingredients

DBV Technologies, creator of Viaskin, a new standard in the treatment of allergies, announced today that it entered into a strategic manufacturing agreement with Sanofi to produce Viaskin's Active Pharmaceutical Ingredients (API), such as the peanut protein extract.

5 Mar 2013

Sanford-Burnham enters into partnership to test furin for treatment of dengue fever

Sanford-Burnham Medical Research Institute and 60- Pharmaceuticals, LLC, have entered into a partnership to test furin, a human proteinase, as a drug target for the treatment of dengue fever, one of the most common infectious diseases in the tropics and subtropics.

5 Mar 2013

Researchers identify distinctive brain patterns associated with general anesthesia drug

Since the mid-1800s, doctors have used drugs to induce general anesthesia in patients undergoing surgery.

5 Mar 2013

World Trade Organization meeting this week to discuss proposed extension of TRIPS transition period for LDCs

"On March 5-6, the Trade-Related Aspects of Intellectual Property Rights Council of the World Trade Organization will meet in Geneva to seal the fate of the proposal lengthening the TRIPS transition period for the 49 least-developed countries [LDCs]," Devex's "The Development Newswire" reports, noting, "The transition period, set to expire July 2013, exempts LDCs from the terms of the TRIPS agreement on patents and test data protection for pharmaceuticals."

5 Mar 2013

Study highlights long-term benefits of early antiretroviral therapy initiated in infants

A study led by University of Massachusetts Medical School professor and immunologist Katherine Luzuriaga, MD, and Johns Hopkins Children's Center virologist Deborah Persaud, MD, highlights the long-term benefits of early antiretroviral therapy (ART) initiated in infants.

5 Mar 2013

Express Scripts finds decline in 2012 U.S. spending on traditional prescription drugs

For the first time in more than 20 years, there was a decrease in 2012 U.S. spending on traditional prescription drugs — primarily pills people take to treat more common diseases such as high cholesterol and high blood pressure — according to new data released today by Express Scripts.

5 Mar 2013

Dr. Reddy's launches generic Zometa

Dr. Reddy's Laboratories announced today that it has launched Zoledronic Acid Injection (4 mg/5 mL), a bioequivalent generic version of Zometa® (zoledronic acid) 4 mg/5 mL Injection in the US market on March 4, 2013, following the approval by the United States Food & Drug Administration (USFDA) of Dr. Reddy's ANDA for Zoledronic Acid Injection (4 mg/5 mL).

5 Mar 2013

Biogen announces FDA acceptance of rFIXFc BLA for treatment of hemophilia B

Biogen Idec announced today that the U.S. Food and Drug Administration (FDA) has accepted the company's Biologics License Application (BLA) for the marketing approval of recombinant factor IX Fc fusion protein (rFIXFc) for the treatment of hemophilia B and granted the company a standard review timeline.

5 Mar 2013

HIV infection may increase risk of acute myocardial infarction

A study that analyzed data from more than 82,000 veterans suggests that infection with the human immunodeficiency virus (HIV) was associated with an increased risk of acute myocardial infarction (AMI, heart attack) beyond what is explained by recognized risk factors, according to a report published Online First by JAMA Internal Medicine, a JAMA Network publication.

4 Mar 2013

Pharmaceutical News

Global Vaccine Summit to be held in Abu Dhabi from Apr. 24-25

Study shows how nanoparticles can be formed to efficiently carry cancer drugs to tumor cells

University of Sunderland pharmaceutical scientists receive CFUK grant for research into cystinosis

Drugs that inhibit buildup of acylcarnitines may block axonal degeneration

Laboratorios Grifols, Cadence announce new supply agreement for OFIRMEV

FDA accepts AMAG’s Feraheme sNDA for review

Study shows how fish oils help lower blood pressure via vasodilation at ion channels

Scientists decode the antihypertensive impact of omega-3 fatty acids

National Jewish Health receives U.S. patent for POPG and related compounds

U.S. researchers report 'functional cure' for infant born with HIV

Much anticipation surrounds push to bring more transparency to medicine

Sanofi, DBV Technologies partner to produce Viaskin's Active Pharmaceutical Ingredients

Sanford-Burnham enters into partnership to test furin for treatment of dengue fever

Researchers identify distinctive brain patterns associated with general anesthesia drug

World Trade Organization meeting this week to discuss proposed extension of TRIPS transition period for LDCs

Study highlights long-term benefits of early antiretroviral therapy initiated in infants

Express Scripts finds decline in 2012 U.S. spending on traditional prescription drugs

Dr. Reddy's launches generic Zometa

Biogen announces FDA acceptance of rFIXFc BLA for treatment of hemophilia B

HIV infection may increase risk of acute myocardial infarction

Exploring the nanoscale: How AFM is transforming cosmetic science

Innovating Texture and Culture in Plant-Based Foods

Advancing brain microphysiological systems (bMPS)

Latest News